From the Department of Endocrine, The Royal Hospital, Seeb, Oman.
From the Department of Research, Oman Medical Specialty Board, Azaiba, Oman.
Ann Saudi Med. 2022 Jul-Aug;42(4):246-251. doi: 10.5144/0256-4947.2022.246. Epub 2022 Aug 4.
Fine needle aspiration cytology (FNAC) of the thyroid has been a reliable and cost-effective method for diagnosing thyroid disorders. Since FNAC results are usually operator dependent, there is a compelling need to explore FNAC accuracy among Omanis.
Describe cytological features of FNAC and assess FNAC accuracy compared to the postsurgical histopathology report.
Retrospective diagnostic accuracy study SETTING: Tertiary care center.
Our study included adult Omani adult patients with thyroid nodules who underwent FNAC from 2014 to 2017 and had final pathology results for patients who underwent thyroid surgery. The results were classified according to the UK Royal college of Pathologists 'Thy' categories. Accuracy of FNAC was calculated by determining false and true positive and negative results based on histopathology findings.
FNAC accuracy (sensitivity and specificity) compared to the postsurgical histopathology.
867 patients with 1359 ultrasound guided FNACs of thyroid nodule; 137 underwent surgery.
The mean age of the 867 patients was 43.7 (13.3) years, with a median of 42 years, and 87.8% were females. Out of 1359 FNACs, 1001 (73.7%) were benign (Thy2), 119 (8.8%) were atypia of undetermined significance or follicular lesion of undetermined significance (Thy3a), 31 (2.3%) were follicular neoplasm or suspicious for a follicular neoplasm (Thy3f), 52 (3.8%) were suspicious for malignancy (Thy4), 55 (4%) were malignant (Thy5), 101 (7.4%) as Unsatisfactory (Thy1). Only 137 patients underwent thyroid surgery, and the FNAC reports were compared with their final histopathology reports. The sensitivity, specificity and total accuracy of FNAC were 80.2%, 98.9% and 89.9%, respectively. The positive and negative predictive values of FNAC were 98.6% and 84.3%, respectively.
Our study findings confirmed that FNAC of the thyroid is a sensitive, specific, and accurate initial tool for the diagnosis of thyroid lesions. Most of the FNACs were benign with a very low malignancy rate. Due to the minimal chance of false negative results and the slow-growing nature of thyroid malignancy, it is important that patients with benign FNAC should have periodic clinical and radiological follow-up.
Retrospective design and single-center study, and thyroid nodule size unavailable.
None.
甲状腺细针穿刺细胞学检查(FNAC)一直是一种可靠且具有成本效益的诊断甲状腺疾病的方法。由于 FNAC 结果通常依赖于操作者,因此迫切需要探索阿曼人 FNAC 的准确性。
描述 FNAC 的细胞学特征,并评估其与术后组织病理学报告相比的准确性。
回顾性诊断准确性研究
三级保健中心。
我们的研究包括 2014 年至 2017 年间接受 FNAC 的成年阿曼成年甲状腺结节患者,以及接受甲状腺手术的患者的最终病理结果。结果根据英国皇家病理学院的“甲状腺”类别进行分类。FNAC 的准确性(灵敏度和特异性)通过基于组织病理学结果确定假阳性、假阴性和真阳性、真阴性结果来计算。
FNAC 准确性(灵敏度和特异性)与术后组织病理学的比较。
867 例接受 1359 例甲状腺结节超声引导 FNAC 的患者;137 例接受手术。
867 例患者的平均年龄为 43.7(13.3)岁,中位数为 42 岁,87.8%为女性。在 1359 例 FNAC 中,1001 例(73.7%)为良性(Thy2),119 例(8.8%)为意义未明的不典型性或滤泡性病变意义未明(Thy3a),31 例(2.3%)为滤泡性肿瘤或滤泡性肿瘤可疑(Thy3f),52 例(3.8%)为恶性可疑(Thy4),55 例(4%)为恶性(Thy5),101 例(7.4%)为不满意(Thy1)。仅 137 例患者接受甲状腺手术,并将 FNAC 报告与最终组织病理学报告进行比较。FNAC 的灵敏度、特异性和总准确性分别为 80.2%、98.9%和 89.9%。FNAC 的阳性和阴性预测值分别为 98.6%和 84.3%。
我们的研究结果证实,甲状腺 FNAC 是一种敏感、特异、准确的甲状腺病变初始诊断工具。大多数 FNAC 为良性,恶性率极低。由于假阴性结果的可能性极小,以及甲状腺恶性肿瘤的生长缓慢,因此对良性 FNAC 的患者进行定期临床和影像学随访非常重要。
回顾性设计和单中心研究,以及甲状腺结节大小不可用。
无。